<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03063164</url>
  </required_header>
  <id_info>
    <org_study_id>33356</org_study_id>
    <nct_id>NCT03063164</nct_id>
  </id_info>
  <brief_title>A Comparison of LASIK Outcomes Using Two Femtosecond Lasers</brief_title>
  <official_title>A Prospective, Randomized, Fellow Eye Comparison of Fellow Eyes Undergoing LASIK With the Intralase IFS150 Versus the Visumax</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edward E. Manche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing LASIK outcomes using two femtosecond lasers
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will have a comprehensive eye examination once they express an interest in the
      study. This includes a slit lamp examination of the front of the eye and a dilated
      fundoscopic examination of the back of the eye. If there is any pathology noted that would
      exclude the patient from the study, then the investigator will inform the patient and make an
      appropriate referral. Patients deemed appropriate for the study after a comprehensive
      examination including computerized videokeratography can be enrolled. Patients will undergo
      bilateral simultaneous eye surgery. Which eye is treated with the Intralase IFS 150 and which
      eye is treated with VisuMax will be randomized so there is a 50% chance for either eye to
      receive one treatment. Patients will be seen on the day of surgery, post op day one, one
      month, three months, six months and one year. Patients will receive topical antibiotics in
      each eye for one week following the procedure. Patients will receive pred forte 1% ophthalmic
      drops for one week after treatment. Patients will also receive vigamox ophthalmic drops for
      four days after treatment. All of this is within the usual and customary standard of care for
      the treatment of patients undergoing LASIK surgery.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Eye to eye comparison</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>ETDRS Uncorrected visual acuity</measure>
    <time_frame>12 months</time_frame>
    <description>ETDRS testing charts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anterior segment ocular coherence tomography measurement of flap thickness</measure>
    <time_frame>One month</time_frame>
    <description>Anterior segment ocular coherence tomography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cochet Bonnet Asthesiometry measurement of corneal sensation</measure>
    <time_frame>One, three, six and twelve months</time_frame>
    <description>Cochet Bonnet Asthesiometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best spectacle corrected visual acuity</measure>
    <time_frame>One, three, six and twelve months</time_frame>
    <description>ETDRS testing charts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aberrometry</measure>
    <time_frame>One three, six and twelve months</time_frame>
    <description>Aberrometry images will be obtained on the iDesign aberrometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire measuring patient preference for laser device</measure>
    <time_frame>Intraoperative, one, three, six and twelve months</time_frame>
    <description>Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcomes with LASIK</measure>
    <time_frame>One month, three months, six months and twelve months</time_frame>
    <description>PROWL study questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Myopia</condition>
  <condition>Astigmatism</condition>
  <arm_group>
    <arm_group_label>Intralase IFS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intralase IFS vs. Visumax</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Visumax</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Visumax vs. Intralase iFS</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intralase IFS150</intervention_name>
    <description>Intralase flap creation</description>
    <arm_group_label>Intralase IFS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Visumax</intervention_name>
    <description>Visumax flap creation</description>
    <arm_group_label>Visumax</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects age 21 and older with healthy eyes. Nearsightedness between -0.25 diopters
             and -11.00 diopters with or without astigmatism of up to 5.00 diopters.

        Exclusion Criteria:

          -  Subjects under the age of 21

          -  Subjects over the age of 60

          -  Subjects with corneal ectatic disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward Manche, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Linda Schwartz</last_name>
    <phone>650 724-2864</phone>
    <email>lschwartz@stanfordhealthcare.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Theresa Enriquez</last_name>
    <phone>650 724-2864</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Byers Eye Institute at Stanford</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edward E Manche, MD</last_name>
      <phone>650-498-7020</phone>
    </contact>
    <investigator>
      <last_name>Edward E Manche, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2017</study_first_submitted>
  <study_first_submitted_qc>February 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 24, 2017</study_first_posted>
  <last_update_submitted>May 29, 2017</last_update_submitted>
  <last_update_submitted_qc>May 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Edward E. Manche</investigator_full_name>
    <investigator_title>Professor of Ophthalmology</investigator_title>
  </responsible_party>
  <keyword>Femtosecond laser</keyword>
  <keyword>Visumax</keyword>
  <keyword>Intralase IFS150</keyword>
  <keyword>LASIK</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

